...
机译:将甲塞米松,梅酚,放线霉素D和抗性禽类非霍奇金高级淋巴瘤治疗组合的多药剂化疗方案的评价:单一中心的经验
Department of Small Animal Clinical Science Institute of Veterinary ScienceUniversity of Liverpool Leahurst CampusNeston UK;
Department of Small Animal Clinical Science Institute of Veterinary ScienceUniversity of Liverpool Leahurst CampusNeston UK;
Department of Small Animal Clinical Science Institute of Veterinary ScienceUniversity of Liverpool Leahurst CampusNeston UK;
Department of Small Animal Clinical Science Institute of Veterinary ScienceUniversity of Liverpool Leahurst CampusNeston UK;
Department of Small Animal Clinical Science Institute of Veterinary ScienceUniversity of Liverpool Leahurst CampusNeston UK;
Department of Small Animal Clinical Science Institute of Veterinary ScienceUniversity of Liverpool Leahurst CampusNeston UK;
Department of Small Animal Clinical Science Institute of Veterinary ScienceUniversity of Liverpool Leahurst CampusNeston UK;
Department of Small Animal Clinical Science Institute of Veterinary ScienceUniversity of Liverpool Leahurst CampusNeston UK;
Department of Small Animal Clinical Science Institute of Veterinary ScienceUniversity of Liverpool Leahurst CampusNeston UK;
Department of Small Animal Clinical Science Institute of Veterinary ScienceUniversity of Liverpool Leahurst CampusNeston UK;
Department of Small Animal Clinical Science Institute of Veterinary ScienceUniversity of Liverpool Leahurst CampusNeston UK;
actinomycin‐D; canine lymphoma; chemotherapy; DMAC; dog; melphalan; rescue; resistant lymphoma;
机译:将甲塞米松,梅酚,放线霉素D和抗性禽类非霍奇金高级淋巴瘤治疗组合的多药剂化疗方案的评价:单一中心的经验
机译:一种地塞米松,梅酚,放线霉素-D和溶细胞化疗议定书作为猫淋巴瘤的救援治疗
机译:地塞米松,美法仑,放线菌素D和胞嘧啶阿拉伯糖苷(DMAC)化疗在复发性犬淋巴瘤中的疗效和不良事件概况
机译:使用化学疗法的单中心经验与Melphalan-Dexamethasone(M-DEX)的Al淀粉样蛋白病和先进器官参与没有资格获得高剂量Melphalan治疗(HDM)
机译:地塞米松美法仑放线菌素D和胞嘧啶阿拉伯糖苷(DMAC)化疗在复发性犬淋巴瘤中的疗效和不良事件概况
机译:一种新的大剂量化疗策略,将苯达莫司汀与依托泊苷,阿糖胞苷和美法仑(BeEAM)同时进行自体干细胞抢救对于治疗耐药/复发性淋巴瘤患者是安全且高效的:一项针对44例患者的I-II期研究